Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Fast Moving Fronts Comments

Return to menu of Fast Moving Fronts

ESI Special Topics, July 2007
Citing URL: http://www.esi-topics.com/fmf/2007/july07-DavidSBredt.html

From •>>JULY 2007

David S. Bredt answers a few questions about this July's fast moving front in the field of Biology & Biochemistry. 


Field: Biology & Biochemistry
Article: Stargazin modulates AMPA receptor gating and trafficking by distinct domains
Authors: Tomita, S;Adesnik, H;Sekiguchi, M;Zhang, W;Wada, K;Howe, JR;Nicoll, RA;Bredt, DS
Journal: NATURE 435 (7045): 1052-1058, JUN 23 2005
Addresses:
Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.
Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.
Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.
Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.
Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan.


   Why do you think your paper is highly cited?




“Our work helps explain how brain cells communicate.”




This article in Nature describes, for the first time, modulation of synaptic transmission by a neurotransmitter receptor auxiliary subunit. This work has enjoyed unusually high impact because the auxiliary subunit, stargazin, modulates the function of AMPA type glutamate receptors, which are the major neurotransmitter receptor types in the brain.

   Does it describe a new discovery, methodology, or synthesis of knowledge?

This work represents an important and unexpected discovery. Previous work suggested that synaptic transmission by AMPA receptors was dictated only by the principle glutamate receptor subunits. Our work demonstrated that stargazin-type auxiliary subunits also play a fundamental role in shaping synaptic transmission.

   Would you summarize the significance of your paper in layman’s terms?

Our work helps explain how brain cells communicate. The primary neurotransmitter used for this communication is glutamate. Our work shows that glutamate receptors do not work alone and that a new auxiliary subunit named "stargazin" also participates. Glutamate receptors mediate fundamental aspects of learning and memory and abnormal glutamate receptor function underlies several neurological and psychiatric diseases. Therefore, this work has broad implications.

   How did you become involved in this research and were there any particular problems encountered along the way?

Our team in this work, which includes, as full partner, Dr. Roger Nicoll at UCSF, became interested in stargazin, as this protein is mutated in "stargazer" mice. These mice suffer from absence epilepsy and cerebellar ataxia. These defects owe to a loss of functional AMPA receptors in specific neuronal types.

Our team determined that this loss of AMPA receptors reflects the fact that stargazin serves as an auxiliary subunit of neuronal AMPA receptors. The scientific community initially questioned this interpretation, as no other neurotransmitter-gated ion channels have known auxiliary subunits. However, this Nature article provides unequivocal proof.

   Where do you see your research leading in the future?

Further studies of the stargazin gene family should provide insights into mechanisms controlling glutamate receptor function and synaptic transmission. This work has important implications for both science and medicine. Also, it will be important to learn whether other neurotransmitter receptors also have crucial auxiliary subunits.

   Are there any social or political implications for your research?

As with any fundamental discovery regarding neuronal function, our work has significance for understanding brain physiology and disease. Because glutamate is the major neurotransmitter in the brain, one can anticipate diverse implications.End

David S. Bredt, M.D., Ph.D.
Vice President, Integrative Biology
Lilly Research Laboratories
Indianapolis, IN, USA


  • Read an interview with David S. Bredt in the Scientists category of in-cites.com.

Return to Fast Moving Fronts | Return to Special Topics main menu
 

ESI Special Topics, July 2007
Citing URL: http://www.esi-topics.com/fmf/2007/july07-DavidSBredt.html

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.